Systemic Lupus Erythematosus Clinical Trials in Durham, North Carolina

4 studies are recruiting for systemic lupus erythematosus in Durham, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)

    Stage
    Phase 3
    Ages
    5 to 17
    Site
    Research Site, Durham, North Carolina
    Locations
    103 in total
    Run by
    AstraZeneca

    See if you can join NCT05835310 on ClinicalTrials.gov

  2. Intervention to Improve Communication and Medication Adherence in Lupus

    CO-LEAD is an intervention to improve patient-provider communication and medication adherence among patients with systemic lupus erythematosus (SLE). The purpose of this study is to optimize the culturally appropriate delivery and test the effect of the CO-LEAD intervention, which includes the foll…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University

    See if you can join NCT06458075 on ClinicalTrials.gov

  3. Duke Lupus Registry

    Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Duke University Medical Center, Durham, North Carolina
    Run by
    Duke University

    See if you can join NCT00512694 on ClinicalTrials.gov

  4. Maternal Autoimmune Disease Research Alliance (MADRA) Registry

    This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy. Prior studies demonstrate the importance…

    Stage
    Not phased
    Ages
    Any age
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University

    See if you can join NCT03276923 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.